January 26, 2015 5:35 AM ET


Company Overview of Endocube

Company Overview

Endocube uses cellular genomics technology to research on endothelium cell biology and the inflammation cascade. Endocube researches to cure disease such as asthma, diabetes and rheumatoid arthritis. The company plans to start selling its own products after it finished its research program. The company was formed in May 2001 by François Amalric, Jean-Philippe Girard and Pierre Bougnères.

Prologue I - La Pyreneenne

BP 27/01

Labège,  31312


Founded in 2001


33 5 62 88 42 50


33 5 62 88 42 51

Key Executives for Endocube

Chief Executive Officer and President
Age: 55
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Immunotech S.A.S. Europe
Consortium National de Recherche en Génomique (CNRG) Europe
LibraGen SA Europe
Microphyt SPAS Europe
GIS Genoplante Recherche Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Endocube, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.